Monday - April 27, 2026

Category Archives: Professional Services

iPSC-Derived NK Cells Pipeline Set to Transform Cancer Immunotherapy Landscape with 15+ Emerging Therapies and Strong Innovation Momentum from Century Therapeutics, Fate Therapeutics | DelveInsight

iPSC-Derived NK Cells Pipeline The iPSC-derived NK cells therapeutic landscape is entering a transformative phase, driven by cutting-edge advancements in cellular engineering, scalable manufacturing, and next-generation immuno-oncology approaches. iPSC-Derived NK Cells Pipeline Set to Transform Cancer Immunotherapy Landscape with 15+ … Continue reading →

Liberty Forge Roofing Explains Why Hiring Experienced Roofing Contractors Is Essential for Georgetown, Texas Homeowners in 2026

Liberty Forge Roofing is educating Georgetown, Texas homeowners on why working with experienced roofing professionals is critical for long-term protection and cost savings. The company highlights how expert roof installation, roof repair, roof leak repair, and commercial roofing services help … Continue reading →

New York No Fault Doctors – Parkchester Opens Its Doors, Serving Car Accident and Workplace Injury Patients Across The Eastern Bronx

New York No Fault Doctors – Parkchester is now serving the Bronx community. New York No Fault Doctors – Parkchester offers a full spectrum of injury-focused medical services under one roof. BRONX, NY – New York No Fault Doctors is proud … Continue reading →

Idiopathic Pulmonary Fibrosis Pipeline Progresses as 80+ Pharma Companies Advance Novel Lung Disease Therapies, Finds DelveInsight | Bristol-Myers Squibb, Genentech, Tvardi Therapeutics, Melius Pharma

Idiopathic Pulmonary Fibrosis Pipeline Insight There are 80+ key companies, including Bristol-Myers Squibb, Genentech, Tvardi Therapeutics, Melius Pharma, Resproly, and others, developing therapies for Idiopathic Pulmonary Fibrosis, with Bristol-Myers Squibb having its IPF drug candidate in the most advanced Phase … Continue reading →

Liver Cancer Pipeline Grows as 70+ Pharma Companies Advance Novel Liver Cancer Therapies, Finds DelveInsight | Can-Fite BioPharma, Yiviva, Tvardi Therapeutics, Biosion, Novartis, Roche

Liver Cancer Pipeline Insight There are 70+ key companies, including Can-Fite BioPharma, Yiviva, Tvardi Therapeutics, Biosion, Novartis, Roche, and others, developing therapies for Liver Cancer, with Can-Fite BioPharma having its Liver Cancer drug candidate in the most advanced Phase III … Continue reading →

Antisense Oligonucleotide Therapeutics Pipeline Grows as 70+ Pharma Companies Advance Novel Treatments for Genetic and Rare Diseases, Finds DelveInsight | Novartis, Wave Life Sciences, Bio-Path Holdin

Antisense Oligonucleotide Therapeutics Pipeline Insights The Antisense Oligonucleotide landscape features 70+ key companies, including Novartis, Wave Life Sciences, Bio-Path Holdings, and others, advancing over 90 pipeline drugs. Companies like Novartis and Wave Life Sciences are currently leading with candidates in … Continue reading →

Generalized Anxiety Disorder Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Fabre-Kramer Pharma, Mind Med, Sunovion, ChemRar Research, Biohaven Pharma, Forest Laboratories

The Key Generalized Anxiety Disorder Companies in the market include – VistaGen Therapeutics, Fabre-Kramer Pharmaceuticals, Mind Med, Sunovion, ChemRar Research, Biohaven Pharma, Forest Laboratories, Sumitomo Pharma, Eli Lilly and Company, Engrail Therapeutics INC, H. Lundbeck A/S, Takeda, Sumitomo Pharma, Astrazeneca, … Continue reading →

Parkinson’s Disease Market: Accelerating Growth and Pipeline Impact by 2034 – DelveInsight | FAScinate Therapeutics, Hoffmann-La Roche, Pharma Two B Ltd., Neuropore Therapies, Olatec Therapeutics, UCB

The Key Parkinson’s Disease Companies in the market include – FAScinate Therapeutics, Hoffmann-La Roche, Pharma Two B Ltd., Neuropore Therapies, Inc., Olatec Therapeutics, UCB Biopharma, Vaxxinity, Modag, Peptron, Kissei Pharmaceutical, Cerevel Therapeutics, and others.   DelveInsight’s “Parkinson’s Disease Market Insights, … Continue reading →

Knee Osteoarthritis Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Merck KGaA, Peptinov, LG Chem, Akan Bioscience, BioTissue, Eupraxia Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Knee Osteoarthritis pipeline constitutes 50+ key companies continuously working towards developing 60+ Knee Osteoarthritis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →